FIELD: medicine.
SUBSTANCE: present invention relates to a transdermal drug containing donepezil for the treatment of dementia, while the drug contains: (a) donepezil or its pharmaceutically acceptable salt as an active component, (b) propylene glycol monocaprylate as solubilizer, and (c) styrene-isoprene-styrene (SIS) block copolymer as adhesive.
EFFECT: transdermal drug, according to the present invention, causes minor skin irritation and has high penetration through the skin.
6 cl, 8 dwg, 11 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRANSCUTANEOUS ABSORPTION PREPARATION CONTAINING STABILIZED DONEPEZIL | 2019 |
|
RU2814017C2 |
| TRANSCUTANEOUS PATCH WITH MICRONEEDLES CONTAINING DONEPEZIL | 2018 |
|
RU2735835C1 |
| INTENSIFIER OF PERCUTANEOUS SUCTION AND TRANSDERMAL MEDICATION WITH ITS APPLICATION | 2009 |
|
RU2504363C2 |
| TRANSDERMALLY ABSORBABLE FORMULATION CONTAINING DONEPEZIL | 2010 |
|
RU2545696C2 |
| PREPARATIVE FORMS OF MEDICATIONS AGAINST DEMENTIA FOR TRANSCUTANEOUS INTRODUCTION | 2006 |
|
RU2428179C2 |
| TRANSCUTANEOUS SUCTION COMPOSITION | 2016 |
|
RU2702356C2 |
| NANO-CAPSULES COVERED WITH CHITOSAN AND THEIR USE | 2019 |
|
RU2790539C2 |
| TRANSDERMAL COMPOSITION CONTAINING DONEPEZIL AS ACTIVE INGREDIENT | 2015 |
|
RU2713207C2 |
| ADHESIVE PRODUCT | 2007 |
|
RU2441649C2 |
| COMPOSITION FOR EXTERNAL USE CONTAINING S-FLURBIPROFEN | 2015 |
|
RU2715907C2 |
